Vaxcell-Bio Therapeutics Co. Ltd
Vaxcell-Bio Therapeutics Co., Ltd. develops and sells cancer immune cell therapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea.
Vaxcell-Bio Therapeutics Co. Ltd (323990) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.044x
Based on the latest financial reports, Vaxcell-Bio Therapeutics Co. Ltd (323990) has a cash flow conversion efficiency ratio of -0.044x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.85 Billion) by net assets (₩65.22 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Vaxcell-Bio Therapeutics Co. Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Vaxcell-Bio Therapeutics Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Vaxcell-Bio Therapeutics Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vaxcell-Bio Therapeutics Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Talga Group Ltd
PINK:TLGRF
|
-0.268x |
|
Apollo Pipes Limited
NSE:APOLLOPIPE
|
0.032x |
|
Namsun Alumini
KO:008350
|
-0.005x |
|
AROAF
PINK:AROAF
|
N/A |
|
Beijing Liven Technology Co. Ltd.
SHE:001259
|
0.006x |
|
Tornado Global Hydrovacs Ltd
V:TGH
|
0.209x |
|
Bliss GVS Pharma Limited
NSE:BLISSGVS
|
0.066x |
|
ReposiTrak
NASDAQ:TRAK
|
0.031x |
Annual Cash Flow Conversion Efficiency for Vaxcell-Bio Therapeutics Co. Ltd (2018–2024)
The table below shows the annual cash flow conversion efficiency of Vaxcell-Bio Therapeutics Co. Ltd from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩71.99 Billion | ₩-10.70 Billion | -0.149x | -31.68% |
| 2023-12-31 | ₩83.49 Billion | ₩-9.42 Billion | -0.113x | +56.45% |
| 2022-12-31 | ₩23.33 Billion | ₩-6.04 Billion | -0.259x | -67.20% |
| 2021-12-31 | ₩30.08 Billion | ₩-4.66 Billion | -0.155x | -62.66% |
| 2020-12-31 | ₩34.67 Billion | ₩-3.30 Billion | -0.095x | +75.92% |
| 2019-12-31 | ₩9.07 Billion | ₩-3.59 Billion | -0.396x | -342.38% |
| 2018-12-31 | ₩-12.20 Billion | ₩-1.99 Billion | 0.163x | -- |